Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Change in Intangibles (2019 - 2025)

Ptc Therapeutics (PTCT) has 7 years of Change in Intangibles data on record, last reported at $34.9 million in Q4 2025.

  • For Q4 2025, Change in Intangibles rose 1179.01% year-over-year to $34.9 million; the TTM value through Dec 2025 reached $291.2 million, up 329.76%, while the annual FY2025 figure was $291.2 million, 329.76% up from the prior year.
  • Change in Intangibles reached $34.9 million in Q4 2025 per PTCT's latest filing, down from $252.8 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at $252.8 million in Q3 2025 and bottomed at $808000.0 in Q1 2025.
  • Average Change in Intangibles over 5 years is $33.1 million, with a median of $18.4 million recorded in 2022.
  • The widest YoY moves for Change in Intangibles: up 2364.89% in 2025, down 98.52% in 2025.
  • A 5-year view of Change in Intangibles shows it stood at $15.3 million in 2021, then increased by 20.0% to $18.4 million in 2022, then grew by 24.6% to $22.9 million in 2023, then tumbled by 88.08% to $2.7 million in 2024, then soared by 1179.01% to $34.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Intangibles were $34.9 million in Q4 2025, $252.8 million in Q3 2025, and $2.7 million in Q2 2025.